The HyperProbe consortium is proud to participate in EANS 2026, the annual congress of the European Association of Neurosurgical Societies and one of the most influential events in the global neurosurgical community.
Each year, the EANS Congress brings together more than 2,000 neurosurgeons, researchers, clinicians, and industry leaders from across Europe and beyond. As a premier platform for scientific exchange and innovation, the congress highlights the latest advances in neurosurgical research, technology, and patient care while fostering collaboration across disciplines.
Against this backdrop, HyperProbe will present its vision for the future of brain surgery through the development of a novel optical imaging device designed to enhance surgical decision-making in real time.
Supporting Better Outcomes for Patients
The ultimate goal of the HyperProbe project is to improve patient care. By providing enhanced intraoperative information, the technology seeks to support more accurate treatment decisions, improve surgical precision, and contribute to better long-term outcomes and quality of life for patients undergoing brain surgery.
As EANS 2026 celebrates the values of responsibility, endurance, and resilience, HyperProbe is excited to join the neurosurgical community in exploring new ways to advance patient-centered innovation and shape the future of neurosurgical care.
We look forward to engaging with researchers, clinicians, and industry partners at EANS 2026 and sharing the latest developments from the HyperProbe project.
